Debunking the Myths of Cannabis
Today’s society is becoming more open to the idea of cannabis as medicine, however, undoing decades of myths; that cannabis has no medical benefit, is a gateway drug to heroin use and that all marijuana users are stoners; are tough concepts to overcome. Patients are interested in achieving relief from their medical conditions while still feeling like themselves but overcoming the misconception that consuming anything with THC will lead to a “high” feeling has been a challenging fallacy to conquer.
With decades of “reefer madness” propaganda to overcome, there are two myths that always seem to make the top of the list.
Myth #1: Inhaling marijuana causes lung cancer.
Fact: The Journal of the American Medical Association (JAMA) published a study in 2012 indicating that inhaling cannabis was not linked with lung damage.
“Marijuana may have beneficial effects on pain control, appetite, mood, and management of other chronic symptoms. Our findings suggest that occasional use of marijuana for these or other purposes may not be associated with adverse consequences on pulmonary function.”
Myth #2: Cannabis is addictive.
Fact: A simple guideline is to consume marijuana responsibly and within moderation. Anything can be considered addictive and harmful when done in excess. The National Institute on Drug Abuse states that around 9% of users become dependent and symptoms of marijuana addiction is linked to a mild withdrawal syndrome which is less than the addiction rate of opiates.
The more studies that are done involving the cannabis plant, the more we’re finding out just how medically beneficial it is in treating a multitude of conditions and symptoms. Knowledge is the key in both understanding the benefit and breaking the stigma endured for so many decades about cannabis.
Through a newly signed agreement, Precision, a Detroit-based company with an extensive portfolio of cannabis extraction, refinement, and processing technologies, will provide state-of-the-art equipment for TerrAscend’s current and future product lines.
TerrAscend Corp., a leading North American cannabis operator, today announced it will open its award-winning Apothecarium branded dispensaries in two Pennsylvania locations; one in Lancaster and a second in Plymouth Meeting.
Micro-dosing is defined as the administration of doses so low that they are unlikely to produce a whole-body effect, but high enough to allow a cellular response. Micro-dosing in cannabis is usually considered 0.5mg to 20mg THC per day.